{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T18:27:49Z","timestamp":1788805669064,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173855"],"award-info":[{"award-number":["82173855"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82161138019"],"award-info":[{"award-number":["82161138019"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFE0119700"],"award-info":[{"award-number":["2022YFE0119700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.drup.2024.101162","type":"journal-article","created":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T13:39:42Z","timestamp":1731159582000},"page":"101162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Zebrafish patient-derived xenograft system for predicting carboplatin resistance and metastasis of ovarian cancer"],"prefix":"10.1016","volume":"78","author":[{"given":"Feifeng","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofen","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhentao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linqian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huafeng","family":"Shou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2024.101162_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14071664","article-title":"The long non-coding RNA SNHG12 as a mediator of carboplatin resistance in ovarian cancer via epigenetic mechanisms","volume":"14","author":"Abildgaard","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.drup.2024.101162_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032288","article-title":"Zebrafish cancer avatars: a translational platform for analyzing tumor heterogeneity and predicting patient outcomes","volume":"24","author":"Al-Hamaly","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.drup.2024.101162_bib3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13046-022-02280-x","article-title":"Zebrafish patient-derived xenograft models predict lymph node involvement and treatment outcome in non-small cell lung cancer","volume":"41","author":"Ali","year":"2022","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.drup.2024.101162_bib4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/pros.22740","article-title":"Enrichment of human prostate cancer cells with tumor initiating properties in mouse and zebrafish xenografts by differential adhesion","volume":"74","author":"Bansal","year":"2014","journal-title":"Prostate"},{"key":"10.1016\/j.drup.2024.101162_bib5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3324\/haematol.2014.110742","article-title":"Focused chemical genomics using zebrafish xenotransplantation as a pre-clinical therapeutic platform for T-cell acute lymphoblastic leukemia","volume":"100","author":"Bentley","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.drup.2024.101162_bib6","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.drup.2024.101162_bib7","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.drup.2024.101162_bib8","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1200\/JCO.2011.36.0354","article-title":"and O. American Society of Clinical, American Society of Clinical Oncology clinical practice guideline update on the use of chemotherapy sensitivity and resistance assays","volume":"29","author":"Burstein","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2024.101162_bib9","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/annonc\/mdz062","article-title":"ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumors and recurrent disease","volume":"30","author":"Colombo","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.drup.2024.101162_bib10","first-page":"49","article-title":"The role of in vitro directed chemotherapy in epithelial ovarian cancer","volume":"3","author":"Ferriss","year":"2010","journal-title":"Rev. Obstet. Gynecol."},{"key":"10.1016\/j.drup.2024.101162_bib11","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1618389114","article-title":"Single-cell functional and chemosensitive profiling of combinatorial colorectal therapy in zebrafish xenografts","volume":"114","author":"Fior","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.drup.2024.101162_bib12","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nrc4015","article-title":"Precision medicine for cancer with next-generation functional diagnostics","volume":"15","author":"Friedman","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2024.101162_bib13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s12020-016-1048-9","article-title":"Patient-derived xenograft in zebrafish embryos: a new platform for translational research in neuroendocrine tumors","volume":"57","author":"Gaudenzi","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.drup.2024.101162_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097897","article-title":"Preclinical therapeutic potential of a nitrosylating agent in the treatment of ovarian cancer","volume":"9","author":"Giri","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.drup.2024.101162_bib15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.drup.2024.101162_bib16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ygyno.2022.04.021","article-title":"State of the science: Contemporary front-line treatment of advanced ovarian cancer","volume":"166","author":"Hinchcliff","year":"2022","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.drup.2024.101162_bib17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/15353702221142612","article-title":"Zebrafish patient-derived xenografts accurately and quickly reproduce treatment outcomes in non-small cell lung cancer patients","volume":"248","author":"Hua","year":"2023","journal-title":"Exp. Biol. Med (Maywood)"},{"key":"10.1016\/j.drup.2024.101162_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/cells12030508","article-title":"Novel Zebrafish Patient-Derived Tumor Xenograft Methodology for Evaluating Efficacy of Immune-Stimulating BCG Therapy in Urinary Bladder Cancer","volume":"12","author":"Kowald","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.drup.2024.101162_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ccell.2021.12.004","article-title":"Functional precision oncology: Testing tumors with drugs to identify vulnerabilities and novel combinations","volume":"40","author":"Letai","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2024.101162_bib20","first-page":"280","article-title":"Epithelial ovarian cancer: Evolution of management in the era of precision medicine","volume":"69","author":"Lheureux","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.drup.2024.101162_bib21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1182\/blood-2016-03-704460","article-title":"A clinically relevant in vivo zebrafish model of human multiple myeloma to study preclinical therapeutic efficacy","volume":"128","author":"Lin","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.drup.2024.101162_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41698-024-00550-9","article-title":"Zebrafish tumour xenograft models: a prognostic approach to epithelial ovarian cancer","volume":"8","author":"Lindahl","year":"2024","journal-title":"NPJ Precis Oncol."},{"key":"10.1016\/j.drup.2024.101162_bib23","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41392-023-01419-2","article-title":"Patient-derived xenograft models in cancer therapy: technologies and applications","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.drup.2024.101162_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112695","article-title":"Pharmacological assessment of zebrafish-based cardiotoxicity models","volume":"148","author":"Maciag","year":"2022","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.drup.2024.101162_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17081375","article-title":"Development of a Patient-Derived Xenograft (PDX) of Breast Cancer Bone Metastasis in a Zebrafish Model","volume":"17","author":"Mercatali","year":"2016","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.drup.2024.101162_bib26","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.2174\/1381612822666160505114326","article-title":"Evolution of Chemosensitivity and Resistance Assays as Predictors of Clinical Outcomes in Epithelial Ovarian Cancer Patients","volume":"22","author":"Monk","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.drup.2024.101162_bib27","doi-asserted-by":"crossref","first-page":"9513","DOI":"10.1038\/s41598-018-27753-y","article-title":"Cysteine allows ovarian cancer cells to adapt to hypoxia and to escape from carboplatin cytotoxicity","volume":"8","author":"Nunes","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drup.2024.101162_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2014.05.002","article-title":"Hematogenous metastasis of ovarian cancer: rethinking mode of spread","volume":"26","author":"Pradeep","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2024.101162_bib29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13046-022-02486-z","article-title":"Harnessing preclinical models for the interrogation of ovarian cancer","volume":"41","author":"Qin","year":"2022","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.drup.2024.101162_bib30","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1517\/17425255.2014.896339","article-title":"In vivo zebrafish assays for analyzing drug toxicity","volume":"10","author":"Raldua","year":"2014","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.drup.2024.101162_bib31","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.2174\/092986706777585059","article-title":"Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic","volume":"13","author":"Ranieri","year":"2006","journal-title":"Curr. Med Chem."},{"key":"10.1016\/j.drup.2024.101162_bib32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s42003-020-1015-0","article-title":"Zebrafish xenografts as a fast screening platform for bevacizumab cancer therapy","volume":"3","author":"Rebelo de Almeida","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.drup.2024.101162_bib33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.semcancer.2022.03.027","article-title":"Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment","volume":"86","author":"Schoutrop","year":"2022","journal-title":"Semin Cancer Biol."},{"key":"10.1016\/j.drup.2024.101162_bib34","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ygyno.2014.04.044","article-title":"Analyses of merlin\/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer","volume":"134","author":"Shah","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.drup.2024.101162_bib35","article-title":"Peptide Transporter 1-Mediated Dipeptide Transport Promotes Hepatocellular Carcinoma Metastasis by Activating MAP4K4\/G3BP2 Signaling Axis","volume":"11","author":"Song","year":"2024","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.drup.2024.101162_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/cells10082077","article-title":"Establishment of Pancreatobiliary Cancer Zebrafish Avatars for Chemotherapy Screening","volume":"10","author":"Tavares Barroso","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.drup.2024.101162_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.101035","article-title":"Progress in characterizing ABC multidrug transporters in zebrafish","volume":"72","author":"Thomas","year":"2024","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.drup.2024.101162_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12030677","article-title":"A Model of a Zebrafish Avatar for Co-Clinical Trials","volume":"12","author":"Usai","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.drup.2024.101162_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071769","article-title":"Zebrafish Xenografts Unveil Sensitivity to Olaparib beyond BRCA Status","volume":"12","author":"Varanda","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.drup.2024.101162_bib40","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1242\/dmm.015784","article-title":"Hooking the big one: the potential of zebrafish xenotransplantation to reform cancer drug screening in the genomic era","volume":"7","author":"Veinotte","year":"2014","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.drup.2024.101162_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101077","article-title":"A novel SIK2 inhibitor SIC-19 exhibits synthetic lethality with PARP inhibitors in ovarian cancer","volume":"74","author":"Wang","year":"2024","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.drup.2024.101162_bib42","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/d41586-018-05890-8","article-title":"The mice with human tumours: Growing pains for a popular cancer model","volume":"560","author":"Willyard","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.drup.2024.101162_bib43","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1111\/jog.14054","article-title":"Establishment of patient-derived xenograft model in ovarian cancer and its influence factors analysis","volume":"45","author":"Wu","year":"2019","journal-title":"J. Obstet. Gynaecol. Res"},{"key":"10.1016\/j.drup.2024.101162_bib44","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13046-017-0631-0","article-title":"Patient-derived xenograft in zebrafish embryos: a new platform for translational research in gastric cancer","volume":"36","author":"Wu","year":"2017","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.drup.2024.101162_bib45","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/jpet.111.188870","article-title":"Pharmacokinetic\/pharmacodynamic modeling of crizotinib for anaplastic lymphoma kinase inhibition and antitumor efficacy in human tumor xenograft mouse models","volume":"340","author":"Yamazaki","year":"2012","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.drup.2024.101162_bib46","doi-asserted-by":"crossref","DOI":"10.1152\/ajpcell.00188.2015","article-title":"Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis","volume":"309","author":"Yeung","year":"2015","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.drup.2024.101162_bib47","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ejso.2013.11.028","article-title":"Conservative treatment of early stage ovarian cancer: oncological and fertility outcomes","volume":"40","author":"Zapardiel","year":"2014","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.drup.2024.101162_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.680491","article-title":"Prediction of Sensitivity and Efficacy of Clinical Chemotherapy Using Larval Zebrafish Patient-Derived Xenografts of Gastric Cancer","volume":"9","author":"Zhai","year":"2021","journal-title":"Front Cell Dev. Biol."}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764624001201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764624001201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:24:11Z","timestamp":1778804651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764624001201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":48,"alternative-id":["S1368764624001201"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2024.101162","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Zebrafish patient-derived xenograft system for predicting carboplatin resistance and metastasis of ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2024.101162","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101162"}}